Form 8-K - Current report:
SEC Accession No. 0001104659-21-133641
Filing Date
2021-11-03
Accepted
2021-11-03 16:11:03
Documents
14
Period of Report
2021-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131488d2_8k.htm   iXBRL 8-K 25759
2 EXHIBIT 23.1 tm2131488d2_ex23-1.htm EX-23.1 2088
3 EXHIBIT 99.1 tm2131488d2_ex99-1.htm EX-99.1 9443
  Complete submission text file 0001104659-21-133641.txt   214702

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA anip-20211103.xsd EX-101.SCH 3219
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20211103_pre.xml EX-101.PRE 22733
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20211103_lab.xml EX-101.LAB 34594
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2131488d2_8k_htm.xml XML 3468
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 211375459
SIC: 2834 Pharmaceutical Preparations